Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schmidt

Showing results (361-370 of 397) with videos related to

Pageof 40
Sort By:
European Journal of Haematology|April 4, 2017
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsEMarc-Andrea Baertsch, Jana Schlenzka, Katharina Lisenko, et al.
Ambio|May 11, 2019
Circumpolar status of Arctic ptarmigan: Population dynamics and trendsEva Fuglei, John-André Henden, Chris T Callahan, et al.
Cell Reports|March 25, 2015
Targeting repulsive guidance molecule A to promote regeneration and neuroprotection in multiple sclerosisElena Demicheva, Yi-Fang Cui, Philip Bardwell, et al.
British Journal of Haematology|December 17, 2016
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2<sup>nd</sup> -line therapy for relapsed and refractory multiple myeloma - a phase II trialUlrich J M Mey, Wolfram Brugger, Heike Schwarb, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2023
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Jannik Stemler, Sibylle C Mellinghoff, Yascha Khodamoradi, et al.
Mycoses|August 12, 2018
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)Markus Ruhnke, Gerhard Behre, Dieter Buchheidt, et al.
Journal of Neurology|October 31, 2019
Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMTMartin Schmidt-Hieber, Dan Engelhard, Andrew Ullmann, et al.
Inflammatory Bowel Diseases|June 30, 2024
Integrating the Patient Perspective to Validate a Measure of Disease Severity in Inflammatory Bowel Disease: Online Survey of Patients and Their PhysiciansAntje Timmer, Johanna Neuser, Dominik de Sordi, et al.
Annals of Hematology|April 18, 2019
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMTMartin Schmidt-Hieber, Gloria Tridello, Per Ljungman, et al.
Bone Marrow Transplantation|May 13, 2026
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimagingMartin Schmidt-Hieber, Roser Velasco, Olaf Penack, et al.
Pageof 40

Showing results (361-370 of 397) with videos related to

Sort By:
Pageof 40
European Journal of Haematology|April 4, 2017
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsEMarc-Andrea Baertsch, Jana Schlenzka, Katharina Lisenko, et al.
Ambio|May 11, 2019
Circumpolar status of Arctic ptarmigan: Population dynamics and trendsEva Fuglei, John-André Henden, Chris T Callahan, et al.
Cell Reports|March 25, 2015
Targeting repulsive guidance molecule A to promote regeneration and neuroprotection in multiple sclerosisElena Demicheva, Yi-Fang Cui, Philip Bardwell, et al.
British Journal of Haematology|December 17, 2016
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2<sup>nd</sup> -line therapy for relapsed and refractory multiple myeloma - a phase II trialUlrich J M Mey, Wolfram Brugger, Heike Schwarb, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2023
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Jannik Stemler, Sibylle C Mellinghoff, Yascha Khodamoradi, et al.
Mycoses|August 12, 2018
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)Markus Ruhnke, Gerhard Behre, Dieter Buchheidt, et al.
Journal of Neurology|October 31, 2019
Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMTMartin Schmidt-Hieber, Dan Engelhard, Andrew Ullmann, et al.
Inflammatory Bowel Diseases|June 30, 2024
Integrating the Patient Perspective to Validate a Measure of Disease Severity in Inflammatory Bowel Disease: Online Survey of Patients and Their PhysiciansAntje Timmer, Johanna Neuser, Dominik de Sordi, et al.
Annals of Hematology|April 18, 2019
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMTMartin Schmidt-Hieber, Gloria Tridello, Per Ljungman, et al.
Bone Marrow Transplantation|May 13, 2026
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimagingMartin Schmidt-Hieber, Roser Velasco, Olaf Penack, et al.
Pageof 40